351
Participants
Start Date
March 31, 2012
Primary Completion Date
January 31, 2015
Study Completion Date
March 31, 2015
E2020
"Subjects in the Group-10 mg:~Week 1 to 4: Once daily donepezil 10 mg and placebo matching donepezil 5 mg, Week 5 to 28: Once daily donepezil 10 mg and placebo matching donepezil 23 mg, Week 29 to 32: Once daily donepezil 5 mg, 10 mg and placebo matching donepezil 23 mg, Week 33 to 52: Once daily donepezil 23 mg"
E2020
"Subjects in the Group-23 mg:~Week 1 to 4: Once daily donepezil 5 mg and 10 mg, Week 5 to 28: Once daily donepezil 23 mg and placebo matching donepezil 10 mg, Week 29 to 32: Once daily donepezil 23 mg, and placebo matching donepezil 5 mg and 10 mg, Week 33 to 52: Once daily donepezil 23 mg"
Anjo
Ōbu
Toyoake
Chikushi
Kitakyushu
Fukuoka
Miyoshi
Ōtake
Amagasaki
Himeji
Morioka
Numakunai
Kida
Takamatsu
Kawasaki
Sagamihara
Yokohama
Yokosuka
Maizuru
Nagasaki
Sendai
Kitamorokata
Ina
Nagaoka
Kurashiki
Ibaraki
Ikeda
Sakai
Sennan
Takatsuki
Age
Iruma
Kasukabe
Tokorozawa
Fuji
Izunokuni
Anan
Bunkyo-ku
Kodaira
Koto
Ōta-ku
Setagaya City
Suginami
Akita
Chiba
Fukuoka
Hiroshima
Kagoshima
Kochi
Kyoto
Nara
Osaka
Saitama
Tokushima
Eisai Co., Ltd.
INDUSTRY